The Gross Margin of Bellicum Pharmaceuticals Inc (BLCM) is 60.71%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | 60.71% |
| 2021-12-31 | 60.71% |
| 2020-12-31 | -352.63% |
| 2019-12-31 | -48.72% |
| 2018-12-31 | -1035.71% |